Neurology News

Youth who accumulated a certain volume of moderate-to-vigorous physical activity in the first 2 weeks following a concussion had reduced odds for persisting symptoms, researchers found.

An Indianapolis-area biopharmaceutical company announced it has raised $30 million in Series B financing to advance investigational tyrosine kinase 2 inhibitors for multiple sclerosis as well as dermatologic conditions.

A biotherapeutics company has raised $120 million to advance its pipeline of cell therapies, including a lead investigational regenerative neural cell therapy candidate to treat drug-resistant mesial temporal lobe epilepsy.

Older adults with a coronary artery calcium score of 0 had more favorable aging indices, including normal cognitive function, vascular function and better hearing, compared with those with CAC scores of 1,000 or greater, data show.

For most of us doctors, it’s the last thing we look at before bed and the first thing when we wake up: the screen of our smartphone or tablet.

For patients with cervical artery dissection initially treated with anticoagulation, switching to antiplatelet therapy at 30 days may prevent bleeding events later, as stroke risk was lower by then, researchers reported.

The European Commission has authorized Skyclarys to treat Friedreich’s ataxia in adults and adolescents aged 16 years and older.

Deficits in processing speed negatively affects memory in individuals with acquired brain injury, strongly suggesting lack of memory recall is associated with poor processing and information acquisition, data show.

Reteplase administered early after stroke symptom onset was superior vs. alteplase for improving 90-day disability, a speaker reported.

Intravenous adrenomedullin given to individuals within 24 hours of acute ischemic stroke was found to be safe at 90 days, according to a presentation from the International Stroke Conference.